Leap Therapeutics Inc(LPTX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

LPTX Leap Therapeutics Inc

交易中 12-20 12:31:13 EST

2.99

+0.21

+7.40%

最高3.00	最低2.75	成交量18.18万
今开2.76	昨收2.78	日振幅8.92%
总市值1.14亿	流通市值7,732万	总股本3,832万
成交额51.79万	换手率0.70%	流通股本2,590万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"LPTX","market":"US","secType":"STK","nameCN":"Leap Therapeutics Inc","latestPrice":2.9857,"timestamp":1734715870250,"preClose":2.78,"halted":0,"volume":181813,"delay":0,"floatShares":25897978,"shares":38317897,"eps":-1.9068,"marketStatus":"交易中","marketStatusCode":2,"change":0.2057,"latestTime":"12-20 12:31:13 EST","open":2.76,"high":3,"low":2.752,"amount":517853.6225693,"amplitude":0.089209,"askPrice":2.98,"askSize":112,"bidPrice":2.96,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.9068,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1734728400000},"adr":0,"adjPreClose":2.78,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":2.8099,"preClose":2.78,"latestTime":"09:13 EST","volume":1756,"amount":4686.9803392,"timestamp":1734704026805},"postHourTrading":{"tag":"盘后","latestPrice":2.78,"preClose":2.78,"latestTime":"19:59 EST","volume":104,"amount":292.9599,"timestamp":1734656387943},"volumeRatio":1.209233,"impliedVol":2.048,"impliedVolPercentile":0.8651},"requestUrl":"/m/hq/s/LPTX/wiki","defaultTab":"wiki","newsList":[{"id":"2493429662","title":"Leap Therapeutics, Inc.盘中异动 早盘急速拉升5.04%报2.92美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2493429662","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493429662?lang=zh_cn&edition=full","pubTime":"2024-12-21 00:28","pubTimestamp":1734712101,"startTime":"0","endTime":"0","summary":"北京时间2024年12月21日00时28分，Leap Therapeutics, Inc.股票出现异动，股价大幅拉升5.04%。Leap Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.25%。Leap Therapeutics, Inc.公司简介：Leap Therapeutics 公司致力于开发治疗癌症的靶向抗体疗法，专注于抑制肿瘤促进途径，靶向癌症特异性细胞表面分子以及激活免疫系统对抗癌细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221002822ab879710&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221002822ab879710&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LPTX","LENZ","BK4563","BK4505","BK4139"],"gpt_icon":0},{"id":"2492976489","title":"Leap Therapeutics, Inc.盘中异动 临近收盘股价大跌5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492976489","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492976489?lang=zh_cn&edition=full","pubTime":"2024-12-20 04:38","pubTimestamp":1734640732,"startTime":"0","endTime":"0","summary":"北京时间2024年12月20日04时38分，Leap Therapeutics, Inc.股票出现波动，股价急速跳水5.17%。Leap Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.78%。Leap Therapeutics, Inc.公司简介：Leap Therapeutics 公司致力于开发治疗癌症的靶向抗体疗法，专注于抑制肿瘤促进途径，靶向癌症特异性细胞表面分子以及激活免疫系统对抗癌细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122004385295ea7ed3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122004385295ea7ed3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LPTX","LENZ","BK4563","BK4505","BK4139"],"gpt_icon":0},{"id":"2492325155","title":"Leap Therapeutics, Inc.盘中异动 股价大跌5.47%报2.94美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492325155","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492325155?lang=zh_cn&edition=full","pubTime":"2024-12-19 03:56","pubTimestamp":1734551811,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日03时56分，Leap Therapeutics, Inc.股票出现波动，股价大幅下挫5.47%。Leap Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.93%。Leap Therapeutics, Inc.公司简介：Leap Therapeutics 公司致力于开发治疗癌症的靶向抗体疗法，专注于抑制肿瘤促进途径，靶向癌症特异性细胞表面分子以及激活免疫系统对抗癌细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219035651ab828cbf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219035651ab828cbf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","LENZ","LPTX","BK4563"],"gpt_icon":0},{"id":"2491201690","title":"Leap Therapeutics, Inc.盘中异动 早盘大幅上涨5.42%报3.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491201690","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491201690?lang=zh_cn&edition=full","pubTime":"2024-12-16 23:12","pubTimestamp":1734361942,"startTime":"0","endTime":"0","summary":"北京时间2024年12月16日23时12分，Leap Therapeutics, Inc.股票出现波动，股价大幅拉升5.42%。Leap Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.39%。Leap Therapeutics, Inc.公司简介：Leap Therapeutics 公司致力于开发治疗癌症的靶向抗体疗法，专注于抑制肿瘤促进途径，靶向癌症特异性细胞表面分子以及激活免疫系统对抗癌细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121623122295ea140b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121623122295ea140b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LPTX","BK4139","BK4505","LENZ","BK4563"],"gpt_icon":0},{"id":"2491301057","title":"Leap Therapeutics, Inc.盘中异动 下午盘急速下跌5.11%报2.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491301057","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491301057?lang=zh_cn&edition=full","pubTime":"2024-12-14 02:41","pubTimestamp":1734115305,"startTime":"0","endTime":"0","summary":"北京时间2024年12月14日02时41分，Leap Therapeutics, Inc.股票出现波动，股价大幅跳水5.11%。Leap Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.37%。Leap Therapeutics, Inc.公司简介：Leap Therapeutics 公司致力于开发治疗癌症的靶向抗体疗法，专注于抑制肿瘤促进途径，靶向癌症特异性细胞表面分子以及激活免疫系统对抗癌细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241214024145ab75fa93&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241214024145ab75fa93&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","LENZ","LPTX","BK4563"],"gpt_icon":0},{"id":"2491336669","title":"Leap Therapeutics, Inc.盘中异动 股价大跌5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491336669","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491336669?lang=zh_cn&edition=full","pubTime":"2024-12-13 00:20","pubTimestamp":1734020446,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日00时20分，Leap Therapeutics, Inc.股票出现异动，股价快速跳水5.30%。Leap Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.94%。Leap Therapeutics, Inc.公司简介：Leap Therapeutics 公司致力于开发治疗癌症的靶向抗体疗法，专注于抑制肿瘤促进途径，靶向癌症特异性细胞表面分子以及激活免疫系统对抗癌细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213002046a1e98404&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213002046a1e98404&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4563","LPTX","BK4505"],"gpt_icon":0},{"id":"2490562869","title":"Leap Therapeutics, Inc.盘中异动 急速下跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490562869","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490562869?lang=zh_cn&edition=full","pubTime":"2024-12-11 23:32","pubTimestamp":1733931126,"startTime":"0","endTime":"0","summary":"北京时间2024年12月11日23时32分，Leap Therapeutics, Inc.股票出现波动，股价快速下跌5.06%。Leap Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.77%。Leap Therapeutics, Inc.公司简介：Leap Therapeutics 公司致力于开发治疗癌症的靶向抗体疗法，专注于抑制肿瘤促进途径，靶向癌症特异性细胞表面分子以及激活免疫系统对抗癌细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211233206984b5896&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211233206984b5896&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LPTX","BK4505","BK4139","LENZ","BK4563"],"gpt_icon":0},{"id":"2489823250","title":"Leap Therapeutics, Inc.盘中异动 早盘大幅拉升6.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489823250","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489823250?lang=zh_cn&edition=full","pubTime":"2024-12-06 23:09","pubTimestamp":1733497773,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日23时09分，Leap Therapeutics, Inc.股票出现异动，股价快速上涨6.35%。Leap Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.58%。Leap Therapeutics, Inc.公司简介：Leap Therapeutics 公司致力于开发治疗癌症的靶向抗体疗法，专注于抑制肿瘤促进途径，靶向癌症特异性细胞表面分子以及激活免疫系统对抗癌细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206230933a1d983ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206230933a1d983ce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","LPTX","BK4563","LENZ"],"gpt_icon":0},{"id":"2489457601","title":"Leap Therapeutics, Inc.盘中异动 早盘股价大涨8.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489457601","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489457601?lang=zh_cn&edition=full","pubTime":"2024-12-05 22:33","pubTimestamp":1733409181,"startTime":"0","endTime":"0","summary":"北京时间2024年12月05日22时33分，Leap Therapeutics, Inc.股票出现异动，股价快速上涨8.47%。Leap Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.12%。Leap Therapeutics, Inc.公司简介：Leap Therapeutics 公司致力于开发治疗癌症的靶向抗体疗法，专注于抑制肿瘤促进途径，靶向癌症特异性细胞表面分子以及激活免疫系统对抗癌细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205223301ab5ffe1f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205223301ab5ffe1f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","LPTX","BK4563","LENZ"],"gpt_icon":0},{"id":"2488905192","title":"Leap Therapeutics, Inc.盘中异动 股价大涨5.70%报2.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488905192","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488905192?lang=zh_cn&edition=full","pubTime":"2024-12-04 22:33","pubTimestamp":1733322791,"startTime":"0","endTime":"0","summary":"北京时间2024年12月04日22时33分，Leap Therapeutics, Inc.股票出现波动，股价急速拉升5.70%。Leap Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.06%。Leap Therapeutics, Inc.公司简介：Leap Therapeutics 公司致力于开发治疗癌症的靶向抗体疗法，专注于抑制肿瘤促进途径，靶向癌症特异性细胞表面分子以及激活免疫系统对抗癌细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204223312abf5c971&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204223312abf5c971&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LPTX","BK4563","BK4505","BK4139","LENZ"],"gpt_icon":0},{"id":"2488949506","title":"Leap Therapeutics, Inc.盘中异动 早盘股价大跌5.17%报2.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488949506","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488949506?lang=zh_cn&edition=full","pubTime":"2024-12-03 22:59","pubTimestamp":1733237994,"startTime":"0","endTime":"0","summary":"北京时间2024年12月03日22时59分，Leap Therapeutics, Inc.股票出现异动，股价快速下挫5.17%。Leap Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.43%。Leap Therapeutics, Inc.公司简介：Leap Therapeutics 公司致力于开发治疗癌症的靶向抗体疗法，专注于抑制肿瘤促进途径，靶向癌症特异性细胞表面分子以及激活免疫系统对抗癌细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203225954971b5f71&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203225954971b5f71&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4563","LPTX","BK4139","BK4505","LENZ"],"gpt_icon":0},{"id":"2486785158","title":"Leap Therapeutics, Inc.盘中异动 股价大涨5.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486785158","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486785158?lang=zh_cn&edition=full","pubTime":"2024-11-27 22:30","pubTimestamp":1732717859,"startTime":"0","endTime":"0","summary":"北京时间2024年11月27日22时30分，Leap Therapeutics, Inc.股票出现异动，股价大幅上涨5.96%。Leap Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Leap Therapeutics, Inc.公司简介：Leap Therapeutics 公司致力于开发治疗癌症的靶向抗体疗法，专注于抑制肿瘤促进途径，靶向癌症特异性细胞表面分子以及激活免疫系统对抗癌细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127223059971a8daa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127223059971a8daa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LPTX","BK4505","BK4563","BK4139","LENZ"],"gpt_icon":0},{"id":"2486831555","title":"Leap Therapeutics, Inc.盘中异动 大幅拉升5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486831555","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486831555?lang=zh_cn&edition=full","pubTime":"2024-11-27 04:54","pubTimestamp":1732654449,"startTime":"0","endTime":"0","summary":"北京时间2024年11月27日04时54分，Leap Therapeutics, Inc.股票出现波动，股价急速上涨5.16%。Leap Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.47%。Leap Therapeutics, Inc.公司简介：Leap Therapeutics 公司致力于开发治疗癌症的靶向抗体疗法，专注于抑制肿瘤促进途径，靶向癌症特异性细胞表面分子以及激活免疫系统对抗癌细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127045409971a8b66&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127045409971a8b66&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4563","BK4505","LPTX","LENZ"],"gpt_icon":0},{"id":"2485588298","title":"Leap Therapeutics, Inc.2024财年第三财季实现净利润-18.18百万美元，同比减少32.70%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485588298","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485588298?lang=zh_cn&edition=full","pubTime":"2024-11-23 00:00","pubTimestamp":1732291215,"startTime":"0","endTime":"0","summary":"11月23日，Leap Therapeutics, Inc.公布财报，公告显示公司2024财年第三财季净利润为-18.18百万美元，同比减少32.70%；其中营业收入为0.00美元，每股基本收益为-0.44美元。从资产负债表来看，Leap Therapeutics, Inc.总负债16.09百万美元，其中短期债务376000.00美元，资产负债比为4.05，流动比率为3.97。机构评级：截至2024年11月23日，当前有5家机构对Leap Therapeutics, Inc.目标价做出预测，其中目标均价为10.70美元，其中最低目标价为5.50美元，最高目标价为16.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000034a24e4823&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000034a24e4823&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","LPTX"],"gpt_icon":0},{"id":"2485260124","title":"Leap Therapeutics, Inc.盘中异动 股价大跌5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485260124","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485260124?lang=zh_cn&edition=full","pubTime":"2024-11-21 02:43","pubTimestamp":1732128220,"startTime":"0","endTime":"0","summary":"北京时间2024年11月21日02时43分，Leap Therapeutics, Inc.股票出现异动，股价大幅下挫5.56%。Leap Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.26%。Leap Therapeutics, Inc.公司简介：Leap Therapeutics 公司致力于开发治疗癌症的靶向抗体疗法，专注于抑制肿瘤促进途径，靶向癌症特异性细胞表面分子以及激活免疫系统对抗癌细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121024340a2492fe6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121024340a2492fe6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4563","BK4139","LPTX","LENZ","BK4505"],"gpt_icon":0},{"id":"2483802112","title":"Leap Therapeutics, Inc.盘中异动 早盘快速下跌5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483802112","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483802112?lang=zh_cn&edition=full","pubTime":"2024-11-14 22:59","pubTimestamp":1731596340,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日22时59分，Leap Therapeutics, Inc.股票出现异动，股价大幅下挫5.33%。Leap Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.63%。Leap Therapeutics, Inc.公司简介：Leap Therapeutics 公司致力于开发治疗癌症的靶向抗体疗法，专注于抑制肿瘤促进途径，靶向癌症特异性细胞表面分子以及激活免疫系统对抗癌细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114225900a237e126&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114225900a237e126&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","LPTX","BK4139","BK4563","BK4505"],"gpt_icon":0},{"id":"2483889226","title":"Leap Therapeutics, Inc.盘中异动 快速拉升6.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483889226","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483889226?lang=zh_cn&edition=full","pubTime":"2024-11-13 22:33","pubTimestamp":1731508400,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日22时33分，Leap Therapeutics, Inc.股票出现异动，股价急速上涨6.77%。Leap Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.07%。Leap Therapeutics, Inc.公司简介：Leap Therapeutics 公司致力于开发治疗癌症的靶向抗体疗法，专注于抑制肿瘤促进途径，靶向癌症特异性细胞表面分子以及激活免疫系统对抗癌细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113223320a23454bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113223320a23454bb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","LENZ","LPTX","BK4563"],"gpt_icon":0},{"id":"2482738800","title":"Leap Therapeutics, Inc.盘中异动 早盘大幅拉升5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482738800","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482738800?lang=zh_cn&edition=full","pubTime":"2024-11-11 22:35","pubTimestamp":1731335746,"startTime":"0","endTime":"0","summary":"北京时间2024年11月11日22时35分，Leap Therapeutics, Inc.股票出现异动，股价急速上涨5.25%。Leap Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.38%。Leap Therapeutics, Inc.公司简介：Leap Therapeutics 公司致力于开发治疗癌症的靶向抗体疗法，专注于抑制肿瘤促进途径，靶向癌症特异性细胞表面分子以及激活免疫系统对抗癌细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111223547971a5b25&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111223547971a5b25&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4563","BK4139","LPTX","LENZ","BK4505"],"gpt_icon":0},{"id":"2482948252","title":"Leap Therapeutics Inc   预计每股亏损48美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2482948252","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482948252?lang=zh_cn&edition=full","pubTime":"2024-11-09 01:01","pubTimestamp":1731085283,"startTime":"0","endTime":"0","summary":"   * Leap Therapeutics Inc    预计在11月11日公布截至2024年9月30日的财报时，季度营收将没有变化(预计)。*    * LSEG 的分析师平均预计 Leap Therapeutics Inc 每股亏损 48 美分。* 华尔街对 Leap Therapeutics Inc 的 12 个月目标价中位数为 12.00 美元，高于其上次收盘价 3.47 美元。11月8日 - 以往季度业绩。除非另有说明，所有数字均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LPTX","LENZ"],"gpt_icon":0},{"id":"2481167699","title":"Leap Therapeutics, Inc.盘中异动 快速跳水5.12%报3.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481167699","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481167699?lang=zh_cn&edition=full","pubTime":"2024-11-08 02:35","pubTimestamp":1731004514,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日02时35分，Leap Therapeutics, Inc.股票出现波动，股价快速跳水5.12%。Leap Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.97%。Leap Therapeutics, Inc.公司简介：Leap Therapeutics 公司致力于开发治疗癌症的靶向抗体疗法，专注于抑制肿瘤促进途径，靶向癌症特异性细胞表面分子以及激活免疫系统对抗癌细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108023514971a52ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108023514971a52ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4505","BK4139","LPTX","BK4563"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.leaptx.com","stockEarnings":[{"period":"1week","weight":-0.1118},{"period":"1month","weight":0.0296},{"period":"3month","weight":0.0036},{"period":"6month","weight":0.4479},{"period":"1year","weight":-0.0544},{"period":"ytd","weight":-0.3293}],"compareEarnings":[{"period":"1week","weight":-0.0302},{"period":"1month","weight":-0.0071},{"period":"3month","weight":0.0314},{"period":"6month","weight":0.0764},{"period":"1year","weight":0.2517},{"period":"ytd","weight":0.2331}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Leap Therapeutics, Inc.最初作为Dekkun Corporation成立于2011年1月3日，一家特拉华州公司。该公司是一家开发新型生物标志物靶向抗体疗法的生物制药公司，旨在通过抑制基本的肿瘤促进途径、靶向癌症特异性细胞表面分子和利用免疫系统攻击癌细胞来治疗癌症患者。他们的策略是识别、获取和开发分子，这些分子将迅速转化为高影响的治疗方法，产生持久的临床效益并提高患者的预后。他们的主要临床阶段项目是DKN-01，一种抑制dickkopf相关蛋白1(“DKK1”)的单克隆抗体。他们目前正在多个正在进行的临床试验中研究DKN-01在食管胃癌、妇科癌症或结直肠癌患者中的应用。他们的第二个临床阶段项目是FL-301，这是一种针对细胞表面表达Claudin18.2的细胞的单克隆抗体。他们还有两个临床前抗体项目，FL-302和FL-501。","yearOnYearQuotes":[{"month":1,"riseRate":0.571429,"avgChangeRate":0.083819},{"month":2,"riseRate":0.375,"avgChangeRate":-0.003011},{"month":3,"riseRate":0.375,"avgChangeRate":-0.044957},{"month":4,"riseRate":0.375,"avgChangeRate":-0.019222},{"month":5,"riseRate":0.375,"avgChangeRate":0.13368},{"month":6,"riseRate":0.375,"avgChangeRate":-0.085816},{"month":7,"riseRate":0.25,"avgChangeRate":-0.025022},{"month":8,"riseRate":0.375,"avgChangeRate":0.017716},{"month":9,"riseRate":0.375,"avgChangeRate":0.051087},{"month":10,"riseRate":0.375,"avgChangeRate":-0.027895},{"month":11,"riseRate":0.25,"avgChangeRate":-0.083965},{"month":12,"riseRate":0.5,"avgChangeRate":0.153634}],"exchange":"NASDAQ","name":"Leap Therapeutics Inc","nameEN":"Leap Therapeutics Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Leap Therapeutics Inc(LPTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Leap Therapeutics Inc(LPTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Leap Therapeutics Inc,LPTX,Leap Therapeutics Inc股票,Leap Therapeutics Inc股票老虎,Leap Therapeutics Inc股票老虎国际,Leap Therapeutics Inc行情,Leap Therapeutics Inc股票行情,Leap Therapeutics Inc股价,Leap Therapeutics Inc股市,Leap Therapeutics Inc股票价格,Leap Therapeutics Inc股票交易,Leap Therapeutics Inc股票购买,Leap Therapeutics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Leap Therapeutics Inc(LPTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Leap Therapeutics Inc(LPTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}